TY  - JOUR

T1  - Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE Trial

JO  - The American Journal of Medicine

PY  - 2018/03/23

AU  - White WB

AU  - Heller SR

AU  - Cannon CP

AU  - Howitt H

AU  - Khunti K

AU  - Bergenstal RM

ED  - 

DO  - DOI: 10.1016/j.amjmed.2018.02.023

PB  - Elsevier BV

VL  - 131

IS  - 7

SP  - 813

EP  - 819.e5

Y2  - 2024/10/22

ER  -